ERBA Diagnostics Mannheim

What ERBA Diagnostics Mannheim does

ERBA Diagnostics Mannheim is the global commercial brand of Transasia Bio-Medicals Ltd., a privately held Indian in-vitro diagnostics (IVD) company founded in 1980 and led by Founder Chairman Suresh Vazirani and Managing Director Nikhil Vazirani. The company manufactures and distributes a full-spectrum IVD portfolio spanning 11 segments: clinical chemistry, hematology, immunology, hemostasis, diabetes management, urinalysis, blood banking, critical care, molecular diagnostics, blood collection tubes, and LIMS. Core instruments combine electrical impedance, tri-angle laser flow cytometry, fluorescence flow cytometry, ion-exchange HPLC, and ELISA processing, with the H 7100 hematology analyzer featuring inbuilt AI Cube Technology for AML/ALL flagging. Manufacturing is located in India at the Andhra Pradesh MedTech Zone (Visakhapatnam) and Sikkim, with international manufacturing through Erba Lachema (Czech Republic) for urinalysis, and global coordination via Erba Global HQ in Dubai Science Park.

Name

ERBA Diagnostics Mannheim

Legal name

Transasia Bio-Medicals Ltd.

Website

https://erbamannheim.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

ERBA Diagnostics Mannheim (Transasia Bio-Medicals) is India's leading in-vitro diagnostics company, manufacturing and distributing analyzers and reagents across 11 IVD segments to clinical labs and hospitals in 100+ countries.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

Keywords

• In-vitro diagnostics
• Clinical chemistry analyzers
• Hematology analyzers
• Immunoassay analyzers
• Diagnostic reagents

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Diagnostic Instruments and Analyzers: Sale of IVD instruments including clinical chemistry analyzers (XL 1000, XL 640, EM 200), hematology analyzers (H 7100, H 560, H 360, ELite 580), electrolyte analyzers, HbA1c systems, coagulation analyzers, ELISA processors, and urine analyzers. Revenue is one-time capital purchase by labs, supplemented by consumables.
2. Reagents and Consumables: Continuous revenue from dedicated reagent packs, controls, calibrators, and consumables specific to each analyzer platform. Includes clinical chemistry reagents (enzymes, substrates, electrolytes), hematology diluents/lysers, ELISA kits (infectious disease, thyroid, fertility), coagulation factors/controls, and blood collection tubes.
3. Software (LIMS): Care Konnekt LIMS software platform offered to laboratories, potentially generating recurring software/service revenue.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

ERBA Diagnostics Mannheim manufactures and sells in-vitro diagnostic (IVD) instruments and the dedicated reagents/consumables that run on them, spanning 11 product segments: clinical chemistry, hematology, immunology, diabetes management, blood banking, hemostasis, urinalysis, critical care, molecular diagnostics, LIMS, and blood collection tubes. Its products are sold primarily to clinical laboratories, hospital networks, blood banks, and government healthcare facilities through direct field sales in India and an international distribution network managed from Dubai under the Erba Global brand.

Product overview

ERBA Diagnostics Mannheim (Transasia Bio-Medicals) offers a comprehensive portfolio of in vitro diagnostic (IVD) solutions spanning 11 product segments: Clinical Chemistry (XL 1000, XL 640 CRS, XL 640, XL 200, EM 360, EM 200, EM Destiny 180, Chem 7, Erba Chem 6, Erba Chem 5X), Critical Care (EC 90 electrolyte analyzer), Diabetes Management (VERTEX Hb HbA1c system), Hematology (H 7100, ELite 580, H 360, H 560, Cube 30 touch, ESL 30, Ves-matic 5, Mini-Cube), Hemostasis (ECL 760, ECL 412, ECL 105), Immunology (Lisa XL, Erba ELAN 30s, Erba Lisa Scan EM, Erba Lisa Wash-II, Lisa Scan EM_LED, Lisa M), Urinalysis (Laura XL, Laura SMART, Laura), Molecular Diagnostics (ErbaMDX COVID-19 RT-PCR), LIMS (Care Konnekt by CAREDATA Infomatics), and Blood Collection Tubes (MonoVaQ & MicroVaQ). The company operates as a platform-plus-modules architecture with instruments and dedicated reagents/consumables for each category. Manufacturing facilities are located in India (Visakhapatnam, Sikkim) with global headquarters supporting the 'Make in India' initiative and exports worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• ErbaLisa: ELISA kits brand for blood banking, immunology, and infectious disease detection including HIV, HCV, HBsAg, Syphilis, Dengue, and COVID-19
• ErbaQik
• EMQAS
• CAREDATA Infomatics

Products and services

• H 7100 Hematology Analyzer Advanced 5-part differential hematology analyzer with fluorescence flow cytometry, inbuilt AI Cube Technology for AML/ALL case flagging, up to 100 samples/hour throughput, and 70 parameters including reticulocyte analysis. Designed for clinical laboratories and research facilities requiring comprehensive CBC, differential, and reticulocyte analysis.
• H 560 Hematology Analyzer Advanced 5-part differential hematology analyzer using tri-angle laser-based flow cytometry for WBC and differentials enumeration. Features 36 parameters including NLR, NRBC, CWBC, malaria P.Vivax flagging, and Mentzer and RDWI indices, with 60 samples/hour throughput and 15 µL sample volume.
• H 360 Hematology Analyzer Automated 3-part differential hematology analyzer with 24 reportable parameters, using electrical impedance method for RBC/PLT/WBC enumeration and cyanide-free colorimetry for hemoglobin testing. Targeted at small and medium pathology labs.
• ELite 580 Hematology Analyzer High-performance hematology system with advanced morphology flagging and data management. Features tri-angle laser-based flow cytometry with 36 reportable parameters and 80 samples/hour throughput.
• Cube 30 Touch ESR Analyzer Automated ESR analyzer using modified Westergren method with dry technology. Features batch mode with stat facility, 25-minute analysis time, and touchscreen colored display for clinical laboratories.
• ESL 30 ESR Analyzer Automated walkaway ESR analyzer for midsize labs meeting CLSI and ICSH guidelines. Provides erythrocyte sedimentation rate testing with minimal operator intervention.
• Ves-matic 5 ESR Analyzer

Quantifiable outcome

• H 7100 delivers up to 100 samples per hour with 70 parameters including reticulocyte analysis and AI-based AML/ALL flagging
• +4 more outcomes

Named customers12 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability1 record

Feature8 records

Partnerships

Two partnerships are on record, tiered core.

• Medica CorporationcoreChannel Partner/ Reseller/ DistributorTransasia Bio-Medicals offers Medica's EasyLyte electrolyte analyzers (EC 90), specifically designed to meet the needs of small to medium-size laboratories. The analyzers feature yes/no prompted operation, simple maintenance, fast results and low cost per sample. Transasia distributes Medica products in India.
• CAREDATA InfomaticscoreTechnology or IntegrationCAREDATA Infomatics is a healthcare technology organization offering LIMS solutions through the Care Konnekt product distributed by ERBA Mannheim. It provides cloud-based platforms to digitally capture patient data, optimize clinical processes for labs and hospitals, with products including Practice Management Systems, Lab Information System, Hospital Information System and Middleware Solutions.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Clinical diagnostics and life science research company with overlapping offerings in quality controls, immunology, and clinical chemistry. Mid-tier global competitor comparable in scale and product breadth.
• ELITech Group: European-headquartered IVD company with chemistry, immunoassay, and microbiology offerings. Comparable mid-tier positioning and emerging-market focus to ERBA's international operations.
• Mindray: Chinese-headquartered global IVD and medical device manufacturer with a comparable emerging-markets focus and a broad clinical chemistry, hematology, and immunoassay portfolio. Mindray's DiaSys acquisition demonstrates the consolidation trajectory ERBA could face or pursue.
• Horiba Medical: Division of Horiba Ltd focused on hematology, clinical chemistry, and urinalysis analyzers. Directly comparable to ERBA's hematology and chemistry segments with similar mid-tier positioning across emerging and developed markets.
• Randox Laboratories: Privately held IVD manufacturer with broad clinical chemistry and immunoassay menus. Similar scale profile and family/private ownership structure to ERBA Mannheim, with comparable emerging-market ambitions.

Broad incumbents

• Sysmex: Global leader in hematology and hemostasis IVD with a strong installed base in emerging markets. Competes with ERBA's H 7100, H 560, ELite 580, and ECL series analyzers, particularly at large hospital and reference labs.
• Siemens Healthineers: Major IVD incumbent with Atellica and Advia Centaur platforms spanning chemistry, immunoassay, hematology, and hemostasis. Relevant competitor for ERBA's XL 1000 and Lisa XL placements at large reference labs.
• Roche Diagnostics: Global IVD incumbent with the broadest assay menu across chemistry, immunoassay, molecular, and tissue diagnostics. Sets the competitive ceiling on technology, menu breadth, and brand pull that ERBA must address in larger hospital accounts.
• Abbott Diagnostics: Diversified IVD player with strong chemistry, immunoassay, hematology, and point-of-care offerings. Competes with ERBA in both Indian hospital labs and emerging-market export channels.
• Beckman Coulter Diagnostics: Danaher-owned IVD platform covering chemistry, immunoassay, hematology, and urinalysis with strong global distribution. Competes with ERBA across multiple instrument categories and reagent menus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ERBA Diagnostics Mannheim